Therapeutic potential of neurotrophic factors in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Therapeutic potential of neurotrophic factors in Alzheimer’s Disease

Published:2021-11-26 Issue: Volume: Page:
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Nasrolahi Ava,Javaherforooshzadeh Fatemeh,Jafarzadeh-Gharehziaaddin Mohsen,Mahmoudi Javad,Asl Khadijeh Dizaji,Shabani Zahra^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-021-06968-9.pdf

Reference112 articles.

1. Huang L-K, Chao S-P, Hu C-J (2020) Clinical trials of new drugs for Alzheimer disease. J Biomed Sci 27(1):1–13

2. Chakraborty A, Diwan A (2020) Alzheimer and it’s possible therapy: a review. J Exp Neurol 1(4):115–122

3. Bature F et al (2017) Signs and symptoms preceding the diagnosis of Alzheimer’s disease: a systematic scoping review of literature from 1937 to 2016. BMJ Open 7(8):e015746

4. Li T, Shi H, Zhao Y (2018) Phosphorylation of microtubule-associated protein tau by mitogen-activated protein kinase in Alzheimer’s disease. IOP Publishing, Bristol

5. Kumar A et al (2016) Current and novel therapeutic molecules and targets in Alzheimer’s disease. J Formos Med Assoc 115(1):3–10

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease;Neurotherapeutics;2024-07

2. Innovative Formulation Platform: Paving the Way for Superior Protein Therapeutics with Enhanced Efficacy and Broadened Applications;Advanced Materials;2024-06-16

3. Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease;Frontiers in Pharmacology;2024-05-21

4. Harnessing Passive Pulsatile Shear Stress for Alzheimer’s Disease Prevention and Intervention;Journal of Alzheimer's Disease;2024-03-19

5. Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders;CNS & Neurological Disorders - Drug Targets;2024-03